Home › Funds › DAFNA Capital Management LLC › STOK

DAFNA Capital Management LLC position in STOK

STOKE THERAPEUTICS INC · Health Care

DAFNA Capital Management LLC reported holding 130,875 shares of STOK (STOKE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.3M, representing 0.82% of its reported portfolio and ranking #28 among its reported holdings. DAFNA Capital Management LLC has disclosed STOK holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)130.88K sh
Reported value held$4.28M
Portfolio Weight0.82%
First reportedQ1 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How DAFNA Capital Management LLC's STOK position evolved

DAFNA Capital Management LLC first disclosed a stake in STOK in Q1 2024 at 145,000 shares (US$2.0M). The position peaked in Q2 2025 at 501,972 shares, worth US$5.7M. Across 10 filings, DAFNA Capital Management LLC increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 130,875 shares valued at US$4.3M. Notable position changes include a 43% increase in Q2 2024 (shares fell 9% over the following quarter), a 160% increase in Q1 2025 (shares rose 71% over the following quarter), a 66% trim in Q3 2025 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 145.00K $1.96M New
Q2 2024 207.43K $2.80M Add
Q3 2024 207.43K $2.55M Hold
Q4 2024 171.10K $1.89M Reduce
Q1 2025 444.00K $2.95M Add
Q2 2025 501.97K $5.70M Add
Q3 2025 169.79K $3.99M Reduce
Q4 2025 108.88K $3.46M Reduce
Q1 2026 130.88K $4.26M Add
Q2 2026 130.88K $4.28M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About STOK and 13F data

STOK (STOKE THERAPEUTICS INC) is a Health Care company. 53 other funds we track also report a position in STOK — the largest reported positions include RTW INVESTMENTS, LP (US$184.0M), Lynx1 Capital Management LP (US$132.1M), Redmile Group, LLC (US$129.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding STOK

All STOK fund holders →

FAQ

How long has DAFNA Capital Management LLC held STOK?

DAFNA Capital Management LLC has disclosed STOK holdings in 10 of the last 10 reported quarters, going back to Q1 2024.

What is DAFNA Capital Management LLC's current position in STOK?

As of Q2 2026, DAFNA Capital Management LLC holds 130.88K shares of STOK (STOKE THERAPEUTICS INC), valued at $4.28M, representing 0.82% of its reported portfolio and ranking #28.

Has DAFNA Capital Management LLC been buying or selling STOK?

In the latest 13F filing (Q2 2026), DAFNA Capital Management LLC held unchanged its position in STOK. The position peaked in Q2 2025 at 501.97K shares.

Which other funds hold STOK?

Other major institutional holders of STOK include RTW INVESTMENTS, LP, Lynx1 Capital Management LP, Redmile Group, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.